Quantcast

New Harvard Study Suggests That Fish Oil Supplements May Help Prevent Type 2 Diabetes

June 27, 2013

A new study released by Harvard University published in the The Journal of Clinical Endocrinology & Metabolism June 2013 suggests that taking fish oil supplements may help prevent Type 2 Diabetes. That’s good news for Canadian gummy vitamin manufacturer, Life Science Nutritionals, best known for their fish-shaped, award-winning Omega 3 gummy supplements.

Burlington, Ontario (PRWEB) June 27, 2013

A new study released by Harvard University published in the The Journal of Clinical Endocrinology & Metabolism June 2013 suggests that taking fish oil supplements may help prevent Type 2 Diabetes. That’s good news for Canadian gummy vitamin manufacturer, Life Science Nutritionals, best known for their fish-shaped, award-winning Omega 3 gummy supplements.

The study examined the effects of fish oil on adiponectin, a hormone associated with lower risk of diabetes and heart disease. Researchers confirmed that taking Omega 3 fish oil does increase adiponectin levels, supporting the benefits of fish oil on insulin sensitivity.

Type 2 Diabetes is a metabolic disease characterized by high blood glucose due to insulin resistance or deficiency. Linked to heart disease, stroke, kidney failure, and other serious health complications, Type 2 Diabetes is considered a “lifestyle” disease because it is linked to poor diet and obesity.

“The research supports what we’ve known in the health industry for years. Omega 3’s are an essential part of our diet that support many metabolic functions and a healthy metabolism,” says Stuart Lowther, Founder and CEO of Life Science Nutritionals. “A diet rich in Omega 3’s supports a healthy heart, brain function, eye development and much more. So these latest results really are no surprise.”

It’s the health benefits of Omega 3 that prompted Lowther to create the first fish oil supplement in a chewable gummy. The great taste and the all-natural formula has made the IronKids Omega 3's the #1 Omega supplement for kids in Canada, and winner of the Best New Product award as well as sharing the PTPA (Parent Tested, Parent Approved) award with their new Adult Essentials Omega 3 Gummies for adults.

Research shows Omega 3 plays an important role in cardiovascular health, cancer treatment, inflammation, depression, age related macular degeneration, ADHD, and dementia. Because of the tremendous health benefits of Omega 3, experts recommend fatty fish a minimum of 2 times per week or the equivalent in Omega 3 supplements (about 500-1000 mg of EPA+DPA per day).

Unfortunately, the traditional Western diet is deficient in Omega 3 fatty acids, which explains why the average Canadian is falling well short of the recommended consumption. One study estimates Canadian consumption of EPA + DPA at 117 mg per day for inland communities and 238 mg per day for coast communities.

“It’s exciting to see all the research that is going into quantifying the health benefits of Omega 3,” says Lowther who hopes the increased awareness will lead to more Canadians taking advantage of the Omega 3 benefits.

About Life Science Nutritionals

Founded in 2005 by health and nutrition expert, Stuart Lowther, Life Science Nutritionals (LSN) specializes the manufacture of premium quality gummy vitamins for kids and adults, under the trade names IronKids and Adult Essentials.

LSN is Canada’s leader in gummy vitamin manufacturing, sales and distribution, winning numerous consumer and parent choice awards, including the Best New Product Award, and the Parent Tested, Parent Approved Award. LSN has been in the top 20 of the PROFIT 500 list of Canada’s Fastest-Growing Companies three years in a row.

Both the IronKids and Adult Essentials Omega 3 supplements contain the highest quality ingredients without added fillers, artificial ingredients, or sugar coatings. The all-natural vitamins are dairy, gluten and nut-free, using fruit and vegetable based colouring instead of artificial food colouring.

For the original version on PRWeb visit: http://www.prweb.com/releases/2013/6/prweb10874817.htm


Source: prweb



comments powered by Disqus